Common Cholesterol-Lowering Drug Found to Slow Vision Loss in Diabetes Patients

First-of-Its-Kind Study Shows Fenofibrate Reduces Eye Disease Progression by 27% ORLANDO, Fla., June 21, 2024 /PRNewswire/ — Today, findings from the Lowering Events in Non-proliferative retinopathy in Scotland (LENS) Trial revealed that fenofibrate, a medication used for many years to…